Announcements Trials

Browse Landscape

Phase

Status

Completed 8 Terminated 2 Active not recruiting 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 1 Mesothelioma, Malignant 1 Fallopian Tube Neoplasms 1 Adenocarcinoma Of Esophagus 1 Adenocarcinoma 1

Interventions

Paclitaxel 16 Carboplatin 15 Bevacizumab 7 Hyperthermic Intraperitoneal Chemotherapy 5 Cisplatin 4 Taxes 3 Gemcitabine 3 Cytoreduction Surgical Procedures 3 Chemotherapy, Adjuvant 3 oregovomab 2 niraparib 2 fluzoparib 2 Topotecan 2 ST 1481 2 Neoadjuvant Therapy 2 Methods 2 Immunohistochemistry 2 Ifosfamide 2 Gene Expression Profiling 2 Filgrastim 2 Educational Status 2 Early Intervention, Educational 2 Amplified Fragment Length Polymorphism Analysis 2 rucaparib 1 pembrolizumab 1 paclitaxel poliglumex 1 olaparib 1 navicixizumab 1 mirvetuximab soravtansine 1 liposomal doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Fallopian Tube Neoplasms × rucaparib × Clear all

NCT03462212 2021-08-27

MITO25

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase 1/2 Unknown

Fallopian Tube Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡